Prognostic impact of CD168 expression in gastric cancer. - Wikidata - wikimedia - TriplyDB

Prognostic impact of CD168 expression in gastric cancer.

Prognostic impact of CD168 expression in gastric cancer.

http://www.wikidata.org/entity/Q33854876

about

Glycosaminoglycans and glycomimetics in the central nervous system Genetic Alterations in Gastric Cancer Associated with Helicobacter pylori Infection.A case of cervical cancer expressed three mRNA variant of Hyaluronan-mediated motility receptor.Prognostic value of discs large homolog 7 transcript levels in prostate cancer.Mechanism of MTA1 protein overexpression-linked invasion: MTA1 regulation of hyaluronan-mediated motility receptor (HMMR) expression and function.Reduced Popdc3 expression correlates with high risk and poor survival in patients with gastric cancer Upregulation of hyaluronan-mediated motility receptor in hepatocellular carcinoma predicts poor survival.RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.Prognostic significance of CD168 overexpression in colorectal cancer Role of receptor for hyaluronan-mediated motility (RHAMM) in human head and neck cancers.Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma Hyaluronic acid in digestive cancers.Hyaluronic Acid in Vascular and Immune Homeostasis during Normal Pregnancy and Preeclampsia.The tumor-associated antigen RHAMM (HMMR/CD168) is expressed by monocyte-derived dendritic cells and presented to T cells Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.Immunohistochemical analysis of RHAMM expression in normal and neoplastic human tissues: a cell cycle protein with distinctive expression in mitotic cells and testicular germ cells.associated factors in the development of gastric cancer with special reference to the early-onset subtype

P2860

Q26823623-58649D22-114A-4692-8E7F-48C6514F978C Q33621927-8B0CE83B-4D93-48BE-B95D-27D078DB1C3A Q33802642-4F61D9B8-5843-420F-8575-833DAEA537B0 Q35070576-2641B359-699C-4DB4-986D-F037613DD426 Q35773975-B1789B4A-378D-40CC-AC64-E67D74026F47 Q35963781-90BAC43F-3350-4DB5-9763-B602BFEA6F89 Q36334849-E6B0F631-0705-4E2A-B65F-633FBC10FE93 Q36366953-8900AD61-22FB-44C2-95AB-CAF5DC0769F2 Q37287615-9E9A7845-AA57-4CFA-88ED-F3B258EC67CA Q38199975-75AE5417-EB3D-478D-9766-C67713376BC7 Q38823693-16C237A4-A734-4593-AE4A-A9137BEC6035 Q38930438-C039AFA9-E769-4BCF-97EA-3B8B424BCC0C Q38994521-3C57F9F5-6F4B-4E48-A1C4-619D8ABD00C3 Q39360428-8053A3E7-110B-4C0F-A805-E74DC8383154 Q41322929-A6E0CB71-C6F0-4113-99C5-72A854454898 Q55363750-858AD27F-53A1-4D39-BB67-1090CCFFBD8A Q57939042-8B64B79A-9A5A-4991-AF11-8BC3BF9F0C04

P2860

Prognostic impact of CD168 expression in gastric cancer.

http://www.wikidata.org/entity/Q33854876

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Prognostic impact of CD168 expression in gastric cancer.

@ast

Prognostic impact of CD168 expression in gastric cancer.

@en

type

label

Prognostic impact of CD168 expression in gastric cancer.

@ast

Prognostic impact of CD168 expression in gastric cancer.

@en

prefLabel

Prognostic impact of CD168 expression in gastric cancer.

@ast

Prognostic impact of CD168 expression in gastric cancer.

@en

P1433

Q33854876-5AC686CB-8ED0-4D7E-A453-43105C257705

P1476

Q33854876-3794FA11-C071-40CD-B8FC-6BEAA76B958C

P2093

Q33854876-04C1EA49-E367-4899-9135-4B791EE07779

Q33854876-0FC23DDA-AFA8-4157-B269-89E0139F6E8C

Q33854876-3B9046D8-D1EE-4952-A92F-E0CA002E51BE

Q33854876-3CE25CFA-68F3-4B1C-9E33-5E2121B2399A

Q33854876-6D3F6AB9-F705-4109-B5F6-95BB210C4126

Q33854876-85DB7549-B0CE-4849-B831-ADD3FC3EC1B7

Q33854876-9CB17419-CFCD-40EE-90BB-9127FE245870

Q33854876-A3F6F0D1-DA8D-492E-B007-131B15DFC098

Q33854876-AB3D51E6-3B26-474F-ACF2-3B23FCC453FD

Q33854876-BF9DF45F-E851-476D-BA42-FCFE20720BB8

P2860

Q33854876-144B3ED0-9707-43B3-8C18-FADFB4B5C703

Q33854876-15C25250-AAD3-40E6-A432-72A70EC73A3F

Q33854876-7626B0E8-5E90-42E0-BACD-168502E560AD

Q33854876-7A3305D8-1D1E-4111-A5EF-C0CF3B1A606F

Q33854876-7A5CB59A-FA15-4285-9CC1-0F5E477FEE71

Q33854876-89EEE1F9-C7B6-482D-A3FE-85268968FE0D

Q33854876-91E8D8E7-84C4-4F3C-902C-65C52B23AD6B

Q33854876-94677102-4D1A-49C3-B4BC-8F134C0EA99D

Q33854876-AA5A5AC2-CA70-40A4-8509-E114B78C6916

Q33854876-B3613358-DB1D-42DE-AA28-1A816641DD0A

P2888

Q33854876-3FBB5B7F-05EA-49B5-922B-D9E6DA89F073

P304

Q33854876-19D7D3EF-AA0F-4D39-98FF-07F63FD2E251

P31

Q33854876-AD84AA26-59B3-4ACC-B4FB-783F30E91ACB

P356

Q33854876-35ED586F-3BD2-4EE9-AD2A-E4D5C8B8E607

P407

Q33854876-89D577B8-B4DD-430B-B863-6C45BB34681C

P478

Q33854876-E0702131-E2D9-46D4-8E27-EDEDC8699AD8

P577

Q33854876-EBED6C11-A228-4279-9E0F-AF5E24AE7EDC

P5875

Q33854876-88FA3B94-FED4-44EA-A28F-0A0C7DBD168B

P6179

Q33854876-8B271BF4-4551-4720-9996-D9048E87C28B

P698

Q33854876-413539F7-CBD4-4CED-93ED-A8CDB2636F39

P932

Q33854876-5799138F-55DD-47CB-B769-863A64716CEA

P356

1471-2407-11-106

P1433

P1476

Prognostic impact of CD168 expression in gastric cancer.

@en

P2093

Hideo Arima

http://www.w3.org/2001/XMLSchema#string

Hiroshi Kurahara

http://www.w3.org/2001/XMLSchema#string

Kita Yoshiaki

http://www.w3.org/2001/XMLSchema#string

Masaki Kitazono

http://www.w3.org/2001/XMLSchema#string

Masataka Matsumoto

http://www.w3.org/2001/XMLSchema#string

Shinichi Ueno

http://www.w3.org/2001/XMLSchema#string

Shoji Natsugoe

http://www.w3.org/2001/XMLSchema#string

Sumiya Ishigami

http://www.w3.org/2001/XMLSchema#string

Takaaki Arigami

http://www.w3.org/2001/XMLSchema#string

Tetsuro Setoyama

http://www.w3.org/2001/XMLSchema#string

P2860

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells

Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis

The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression

The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells

Increased hyaluronan at sites of attachment to mesentery by CD44-positive mouse ovarian and breast tumor cells.

Two-marker protein profile predicts poor prognosis in patients with early rectal cancer

Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.

Androgen receptor regulates CD168 expression and signaling in prostate cancer.

Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.

RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53.

P2888

1471-2407-11-106

P304

106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2407-11-106

http://www.w3.org/2001/XMLSchema#string

P407

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50849678

http://www.w3.org/2001/XMLSchema#string

P6179

1019079801

http://www.w3.org/2001/XMLSchema#string

P698

21435222

http://www.w3.org/2001/XMLSchema#string

P932

3076262

http://www.w3.org/2001/XMLSchema#string